Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.
Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also ...
Compounded semaglutide - the active ingredient in the blockbuster drugs mixed with other additives - is produced by ...
Nimacimab enhanced weight loss induced by semaglutide.
The success of weight-loss drugs has driven demand for injectable compounds that claim to improve everything from sleep to ...
More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.
While the food sector is struggling, the fashion industry looks set to benefit from the increasing use of weight-loss jabs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results